SCHEMBL24733475

SCHEMBL24733475

CN1CCN(Cc2cccc(Cn3c(=O)[nH]c4c(Cl)nc5ccccc5c43)c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.45
TP53 P04637 2/20 0.44
ALOX15 P16050 2/20 0.44
TSHR P16473 2/20 0.44
ALDH1A1 P00352 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
FGFR1 P11362 2/20 0.42
PDGFRB P09619 1/20 0.42
KDR P35968 1/20 0.42
FLT1 P17948 1/20 0.42
NCF1 P14598 1/20 0.42
TNKS O95271 1/20 0.42
PARP1 P09874 1/20 0.42
HTR1A P08908 2/20 0.41
HTR7 P34969 1/20 0.41
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
IDO2 Q6ZQW0 1/20 0.41
ACP1 P24666 1/20 0.41
TLR7 Q9NYK1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29809234 1.00 MC4R (0.45) MC4RTP53ALOX15TSHRALDH1A1
SCHEMBL24732778 0.91 ALDH1A1 (0.44) TP53ALOX15TSHRALDH1A1NPSR1
SCHEMBL29809343 0.91 ALDH1A1 (0.44) TP53ALOX15TSHRALDH1A1NPSR1
SCHEMBL29809002 0.90 MAOB (0.43) TSHRALDH1A1ACP1TLR7
SCHEMBL24732724 0.90 MAOB (0.43) TSHRALDH1A1ACP1TLR7
SCHEMBL28802656 0.89 ADORA2A (0.44) ALOX15TSHRALDH1A1NPSR1PARP1
SCHEMBL24733037 0.88 MEN1 (0.48) TSHRALDH1A1NCF1TNKSPARP1
SCHEMBL24732752 0.88 TLR7 (0.51) MC4RFGFR1PDGFRBKDRFLT1
SCHEMBL29809183 0.88 MEN1 (0.48) TSHRALDH1A1NCF1TNKSPARP1
SCHEMBL29809298 0.88 TLR7 (0.51) MC4RFGFR1PDGFRBKDRFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150346-A1 CLASS OF HETEROAROMATIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF INNOVSTONE THERAPEUTICS LIMITED (CN) 2024-05-09 US disclosed
WO-2022161420-A1 CLASS OF HETEROAROMATIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 上海翊石医药科技有限公司 2022-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240150346-A1 CLASS OF HETEROAROMATIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF TLR7, TLR1, TLR8 MC4R 250/4885TP53 2717/4885ALOX15 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.